Top Markets
#1 0G 0G +24.46%
#2 SAFEcoin SAFEcoin +21.99%
#3 Zora Zora +20.33%
#4 Axelar Axelar +19.88%
#5 Full Moon Full Moon +18.98%
#6 AI XOVIA AI XOVIA +17.52%
#7 Merlin's Seal BTC Merlin's Seal BTC +16.60%
#8 Cysic Cysic +16.30%
#9 VVS Finance VVS Finance +15.88%
#10 Apertum Apertum +13.84%
Coin of the day
0G 0G
Settings
Language
ENGLISH
Currency
USD
Theme
Beijing Scitop Bio-tech Co., Ltd. Beijing Scitop Bio-tech Co., Ltd.

Beijing Scitop Bio-tech Co., Ltd.

300858
Rank in Stocks #12706
Beijing Scitop Bio-tech Co., Ltd. operates in China, specializing in the... Beijing Scitop Bio-tech Co., Ltd. operates in China, specializing in the research, production, and sale of probiotic lactic acid bacteria and their related derivatives. The company's product range also encompasses complex food additives, consumer-grade probiotic items, and specialized microecological preparations for both animal and plant applications. These diverse solutions are utilized across various industries, including food processing, healthcare, livestock farming, and crop cultivation. Founded in 2003, Beijing serves as the company's main operational hub.
Share Price
$2.11
Market Cap
$556.72M
Change (1 day)
-0.75%
Change (1 year)
-21.57%
Country
CN
Trade Beijing Scitop Bio-tech Co., Ltd. (300858)

Category

Healthcare
Revenue for Beijing Scitop Bio-tech Co., Ltd. (300858)
Revenue in Aug 2026 TTM: 0
According to Beijing Scitop Bio-tech Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Beijing Scitop Bio-tech Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH